Stay updated on Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page
- Check4 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, representing a small update to the study page without substantive content changes.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedAdrenal cortex carcinoma added as a keyword/MeSH term on the study page.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision updated to v3.5.0; previous revision v3.4.3 has been removed.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision: v3.4.2 was added and the government funding status notice about potential data unavailability and response delays was removed.SummaryDifference0.4%

Stay in the know with updates to Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page.